Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Shock, Hemorrhagic | 14 | 2021 | 48 | 1.980 |
Why?
|
| Valproic Acid | 11 | 2021 | 15 | 1.600 |
Why?
|
| Brain Injuries, Traumatic | 10 | 2021 | 46 | 1.410 |
Why?
|
| Histone Deacetylase Inhibitors | 8 | 2021 | 30 | 1.080 |
Why?
|
| Diagnostic Imaging | 2 | 2025 | 70 | 0.930 |
Why?
|
| Adenocarcinoma | 2 | 2025 | 300 | 0.910 |
Why?
|
| Pancreatic Neoplasms | 3 | 2025 | 548 | 0.860 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2025 | 146 | 0.850 |
Why?
|
| Multiple Trauma | 5 | 2019 | 23 | 0.730 |
Why?
|
| Resuscitation | 7 | 2019 | 59 | 0.680 |
Why?
|
| Disease Models, Animal | 14 | 2021 | 1508 | 0.420 |
Why?
|
| Swine | 11 | 2021 | 238 | 0.370 |
Why?
|
| Histone Deacetylase 6 | 2 | 2019 | 8 | 0.300 |
Why?
|
| Sepsis | 2 | 2019 | 86 | 0.280 |
Why?
|
| Animals | 18 | 2024 | 10699 | 0.250 |
Why?
|
| Theranostic Nanomedicine | 1 | 2024 | 25 | 0.210 |
Why?
|
| Neuroprotection | 2 | 2021 | 14 | 0.190 |
Why?
|
| Brain | 2 | 2018 | 770 | 0.180 |
Why?
|
| Apoptosis | 3 | 2019 | 780 | 0.170 |
Why?
|
| Aorta | 2 | 2019 | 124 | 0.170 |
Why?
|
| Recovery of Function | 2 | 2018 | 123 | 0.160 |
Why?
|
| Nanoparticles | 1 | 2024 | 291 | 0.160 |
Why?
|
| Pyridazines | 1 | 2019 | 8 | 0.150 |
Why?
|
| Balloon Occlusion | 1 | 2019 | 4 | 0.150 |
Why?
|
| Brain Edema | 1 | 2019 | 21 | 0.150 |
Why?
|
| Hydroxamic Acids | 1 | 2018 | 22 | 0.150 |
Why?
|
| Brain Injuries | 1 | 2019 | 50 | 0.140 |
Why?
|
| Neurofilament Proteins | 1 | 2018 | 5 | 0.140 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2018 | 21 | 0.140 |
Why?
|
| Intestines | 1 | 2019 | 118 | 0.140 |
Why?
|
| Plasma | 1 | 2018 | 32 | 0.140 |
Why?
|
| Neuroprotective Agents | 1 | 2018 | 52 | 0.140 |
Why?
|
| Indoles | 1 | 2018 | 111 | 0.140 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2017 | 13 | 0.130 |
Why?
|
| Proteome | 1 | 2018 | 79 | 0.130 |
Why?
|
| Hippocampus | 1 | 2019 | 198 | 0.130 |
Why?
|
| Blood-Brain Barrier | 1 | 2018 | 97 | 0.130 |
Why?
|
| Lung Injury | 1 | 2017 | 33 | 0.130 |
Why?
|
| Exosomes | 1 | 2018 | 96 | 0.130 |
Why?
|
| Female | 11 | 2021 | 15634 | 0.120 |
Why?
|
| Transcriptome | 1 | 2018 | 231 | 0.120 |
Why?
|
| Neurons | 1 | 2018 | 297 | 0.120 |
Why?
|
| Humans | 8 | 2025 | 28884 | 0.120 |
Why?
|
| Biomarkers | 1 | 2018 | 777 | 0.110 |
Why?
|
| Cognition | 1 | 2017 | 331 | 0.110 |
Why?
|
| Inflammation | 1 | 2019 | 668 | 0.110 |
Why?
|
| Random Allocation | 3 | 2018 | 151 | 0.100 |
Why?
|
| Survival Rate | 3 | 2019 | 432 | 0.100 |
Why?
|
| Sus scrofa | 2 | 2019 | 12 | 0.070 |
Why?
|
| Peroxidase | 2 | 2019 | 39 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 554 | 0.070 |
Why?
|
| Mice | 3 | 2024 | 4808 | 0.060 |
Why?
|
| Rats | 2 | 2019 | 1588 | 0.060 |
Why?
|
| Time Factors | 2 | 2019 | 1613 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 194 | 0.050 |
Why?
|
| Pancreatectomy | 1 | 2022 | 58 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2024 | 236 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2022 | 480 | 0.040 |
Why?
|
| Erythrocyte Transfusion | 1 | 2019 | 15 | 0.040 |
Why?
|
| ADAM17 Protein | 1 | 2019 | 13 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2019 | 58 | 0.040 |
Why?
|
| Fluid Therapy | 1 | 2019 | 14 | 0.040 |
Why?
|
| Punctures | 1 | 2018 | 17 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 21 | 0.040 |
Why?
|
| Acute Lung Injury | 1 | 2018 | 12 | 0.040 |
Why?
|
| Neuronal Plasticity | 1 | 2019 | 51 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2019 | 119 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2019 | 221 | 0.040 |
Why?
|
| Spleen | 1 | 2018 | 114 | 0.040 |
Why?
|
| Phagocytosis | 1 | 2018 | 80 | 0.040 |
Why?
|
| GABA Agents | 1 | 2018 | 4 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 612 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2019 | 357 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 251 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 82 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2019 | 198 | 0.030 |
Why?
|
| Heart Rate | 1 | 2019 | 382 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2019 | 515 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2018 | 270 | 0.030 |
Why?
|
| Cell Survival | 1 | 2019 | 419 | 0.030 |
Why?
|
| RNA | 1 | 2018 | 111 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2017 | 65 | 0.030 |
Why?
|
| Myocardium | 1 | 2018 | 196 | 0.030 |
Why?
|
| Caveolin 1 | 1 | 2017 | 43 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2019 | 191 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 585 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 251 | 0.030 |
Why?
|
| Proteomics | 1 | 2018 | 197 | 0.030 |
Why?
|
| Macrophages | 1 | 2018 | 305 | 0.030 |
Why?
|
| Lung | 1 | 2018 | 382 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2018 | 334 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 1022 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 1658 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 841 | 0.020 |
Why?
|
| Male | 2 | 2019 | 13934 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2018 | 1469 | 0.020 |
Why?
|